Soteropoulos Paula bought DNTH
May 8, 2026 · Form 4 insider transaction
Soteropoulos Paula bought 599 shares of Dianthus Therapeutics, Inc. at $8.44 per share, a transaction worth $5.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
599
Price
$8.44
Total value
$5.1K
InsiderSoteropoulos Paula
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 8, 2026
Filing dateMay 11, 2026
Shares owned after599
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2025.